SAN DIEGO, Nov. 28, 2018 /PRNewswire/ -- Epic Sciences, Inc. (Epic) announced today that they will be presenting new data on inter- and intra-patient phenotypic heterogeneity and the use of HER2 and AR expression in metastatic breast cancer circulating tumor cells at the 2018 San Antonio Breast Cancer Symposium (SABCS) from December 4 - 8 in San Antonio, TX. Epic will be showcasing this data during the Detection/Diagnosis: Circulating Tumor Cells session on December 6.
"Profiling single tumor cells for functional protein, morpohologic and genomic differences provides novel insights into understanding of tumor heterogeneity as it relates to clinical progression," said Ryan Dittamore, chief of medical innovation at Epic Sciences. "We expect that our use of single cell pheno-genomics will enable insight into therapeutic resistance and may identify novel therapeutic opportunities in metastatic breast cancer."
Following are the details for the two poster sessions:
Further information is available on the Company's website, www.epicsciences.com. Stay in touch on LinkedIn or on Twitter @EpicSciences.
Epic Sciences Media Contact: Jennifer Guzman, Director of Marketing, [email protected], +1.858.216.2217
Advertisement
"Profiling single tumor cells for functional protein, morpohologic and genomic differences provides novel insights into understanding of tumor heterogeneity as it relates to clinical progression," said Ryan Dittamore, chief of medical innovation at Epic Sciences. "We expect that our use of single cell pheno-genomics will enable insight into therapeutic resistance and may identify novel therapeutic opportunities in metastatic breast cancer."
Advertisement
Following are the details for the two poster sessions:
- Abstract: P3-01-07Poster: Enabling HER2 and androgen receptor (AR) protein expression and localization in circulating tumor cells (CTCs) of ER(+/-)HER2(-) metastatic breast cancer (MBC) patients (pts), Authors: Ontiveros P, Landaverde C, Graf R, Levin MK, Hippely S, Wang Y, Landers M, Dittamore R, O'Shaughnessy JA. Epic Sciences, San Diego, CA; Baylor Scott & White Research Institute, Dallas, TX.Location: Hall 1Date and Time: Thursday, December 6, 5:00 pm – 7:00 pm CST
- Abstract: P3-01-14Poster: Diverse inter- and intra-patient circulating tumor cells (CTCs) phenotypic heterogeneity identi?ed in metastatic breast cancer (MBC) cohort.Authors: Wang Y, Hom B, Ontiveros P, Landaverde C, Roth E, Levin MK, Hippely S, Landers M, Dittamore R, O'Shaughnessy JA. Epic Sciences, San Diego, CA; Baylor Scott & White Research Institute, Dallas, TX.Location: Hall 1Date and Time: Thursday, December 6, 5:00 pm – 7:00 pm CST
Further information is available on the Company's website, www.epicsciences.com. Stay in touch on LinkedIn or on Twitter @EpicSciences.
Epic Sciences Media Contact: Jennifer Guzman, Director of Marketing, [email protected], +1.858.216.2217
View original content:http://www.prnewswire.com/news-releases/epic-sciences-to-present-data-at-sabcs-2018-300756658.html
SOURCE Epic Sciences